# Orlucent

Source: https://onco.cc/companies/orlucent/  
OnCo record `orlucent` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Orlucent is a California company making a handheld imaging system that uses a fluorescent agent on the skin to judge whether a mole is turning into melanoma. It is in clinical trials and not yet approved for diagnosis in the United States.

## Summary

Orlucent, Inc., of Los Gatos, California, has developed a handheld fluorescent molecular imaging system, the Orlucent System, to assess the likelihood of a mole's transition to melanoma; the website states that it is in clinical trials and for research use only in the United States. In fiscal year 2026 NCI awarded it USD 1,556,529 under SBIR Direct-to-Phase II grant 1R44CA306680-01A1 to develop manufacturing controls for ORL1, the fluorescent imaging agent used by its skin fluorescent imaging system; the award abstract reports 100 per cent sensitivity and 95.7 per cent specificity in distinguishing melanomas from non-melanomas in preliminary studies.

## Fields

- Kind: Company
- Last checked: 2026-11-04
- Also known as: Orlucent, Inc.; ORLUCENT, INC.
- HQ: Los Gatos, CA
- Type: imaging
- Website: https://orlucent.com/

## Notes

- The sensitivity and specificity figures are from preliminary studies reported in the company's award abstract, not a published trial. Founding year not stated. Read on orlucent.com and NIH RePORTER on 4 November 2026.

## Sources

- Official website: https://orlucent.com/
- NIH RePORTER: award 1R44CA306680-01A1: https://reporter.nih.gov/project-details/11410547

## Connected records

- cancers: [Melanoma](https://onco.cc/cancers/melanoma/)
- fronts: [Diagnostics & Biomarkers](https://onco.cc/fronts/diagnostics/), [Early Detection & Screening](https://onco.cc/fronts/early-detection/), [Imaging](https://onco.cc/fronts/imaging/)
- technologies: [Optical & fluorescence imaging](https://onco.cc/technologies/optical-imaging/)
- drugs: [Orlucent System](https://onco.cc/drugs/orlucent-system/)

---
JSON: https://onco.cc/api/v1/entities/orlucent.json